Tissue-type plasminogen activator (t-PA) is a serine protease that plays a central role in the regulation of intravascular thrombolysis. The acute release of t-PA in vivo is induced by a variety of stimuli including exercise, trauma, and neural stimulation. These types of stimuli also result in sympathoadrenal activation and exocytotic release of amines and proteins from catecholamine storage vesicles of the adrenal medulla and sympathetic neurons. Therefore, we tested the hypothesis that t-PA is packaged in and released directly from catecholamine storage vesicles, using several chromaffin cell sources including the rat pheochromocytoma PC-12 chromaffin cell line, primary cultures of bovine adrenal chromaffin cells, and human pheochromocytoma.
Tissue plasminogen activator (t-PA)1 is a serine protease playing the dominant role in elimination of fibrin from the vasculature by activating the circulating zymogen, plasminogen, to the primary fibrinolytic enzyme, plasmin (1, 2). The major source of circulating t-PA under basal conditions is thought to be the endothelial cell (3, 4). It is generally believed that t-PA follows the constitutive secretory pathway (5). However, t-PA can be released into the circulation within minutes in response to distinct types of stimulation (6 -8). The rapidity of this response suggests secretion from stored pools rather than de novo synthesis (9). However, the mechanisms by which this response occurs in vivo and the cellular sources are not known.Specific stimuli have been identified that induce the acute release of t-PA. Included among these stimuli are exercise (10), mental stress (11, 12), electroconvulsive therapy (13), and surgery (11). Of note, these types of stimuli also activate the sympathoadrenal system causing exocytotic release of amines and proteins from catecholamine storage vesicles of the adrenal medulla and sympathetic neurons (14). In addition, t-PA is present in neuroendocrine tissues (15)(16)(17)(18)(19), including the adrenal medulla (20). Therefore, we tested the hypothesis that t-PA is packaged in and released directly from catecholamine storage vesicles, by investigating t-PA expression, subcellular localization, and secretagogue-mediated t-PA release from several chromaffin cell sources. These included rat PC-12 cells, a well-established chromaffin cell line with abundant catecholamine storage vesicles (21), as well as primary bovine adrenal chromaffin cells, and human pheochromocytoma, a catecholamine-producing tumor of the adrenal medulla, and hence a source of human chromaffin cells. Our results demonstrate that t-PA is expressed in chromaffin cells where it is targeted to the regulated pathway of secretion (into catecholamine storage vesicles) and is co-released with catecholamines by chromaffin cell stimulation. These results suggest that catecholamine storage vesicles may serve as a